Merck & Company ( (MRK) ) has released its Q4 earnings. Here is a breakdown of the information Merck & Company presented to its investors.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Looking forward, Merck anticipates 2025 worldwide sales to be between $64.1 billion and $65.6 billion, with non-GAAP EPS expected to range from $8.88 to $9.03. The company remains optimistic about its growth potential, driven by its continued focus on innovation, strategic partnerships, and a diverse product pipeline.
